# EBV mRNA Vaccine for the Prevention of EBV-Related Diseases After Allo-HSCT

> **NCT07674199** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **The General Hospital of Western Theater Command** · enrollment: 20 (estimated)

## Conditions studied

- Patients After Hematopoietic Stem Cell Transplantation

## Interventions

- **BIOLOGICAL:** Intramuscular injection of EBV mRNA vaccine (WGc-0401 injection)

## Key facts

- **NCT ID:** NCT07674199
- **Lead sponsor:** The General Hospital of Western Theater Command
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-18
- **Primary completion:** 2030-12-31
- **Final completion:** 2031-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07674199

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07674199, "EBV mRNA Vaccine for the Prevention of EBV-Related Diseases After Allo-HSCT". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07674199. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*